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Abstract
Background: Insulin resistance (IR) is an important risk factor for subclinical atherosclerosis. This study evaluated the
relationship between the triglyceride glucose (TyG) index, which is a simple and reliable surrogate marker for IR,
and arterial stiffness.
Methods: This study included 2560 Korean subjects without a previous history of coronary artery disease, stroke,
and malignancies who participated in a community-based cohort study. Arterial stiffness was measured using the
brachial-ankle pulse wave velocity (baPWV).
Results: All participants were stratified into four groups based on the quartile of the TyG index. The prevalence of
metabolic syndrome and diabetes significantly increased with increasing TyG index quartile. The mean baPWV
was significantly different among all groups (group I [lowest]: 1421 ± 242 vs. group II: 1480 ± 244 vs. group III:
1534 ± 260 vs. group IV [highest]: 1575 ± 279 cm/s; p < 0.001). The TyG index values were correlated with
baPWV (r = 0.224, p < 0.001). Multiple regression analysis showed that age (β = 0.410), male gender (β = 0.051),
increased blood pressure (β = 0.266), and TyG index (β = 0.158) were associated with baPWV (p < 0.05,
respectively). TyG index was independently related to baPWV in both non-diabetics and diabetics.
Conclusions: The TyG index is independently associated with arterial stiffness in a relatively healthy Korean
population.
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Introduction
Cardiovascular (CV) disease is a major cause of morbid-
ity and mortality. It is well-established that insulin resist-
ance (IR) is associated with an increased risk of
metabolic abnormalities, including hyperglycemia, dys-
lipidemia, and hypertension [1, 2]. In addition, a number
of studies have revealed that IR is one of the most im-
portant contributing factors to CV disease [3, 4].
Recently, the triglyceride glucose (TyG) index was
used as a simple and reliable surrogate marker of IR.
Several studies reported that the TyG index is closely
correlated with the homeostatic model assessment of in-
sulin resistance (HOMA-IR) index, which has been trad-
itionally used to measure IR [5–7]. However, there is a
paucity of data on the relationship between the TyG
index and subclinical atherosclerosis, especially arterial
stiffness which has independent prognostic value for the
risk of CV events. Moreover, although previous studies
suggested the possibility of a somewhat different athero-
sclerotic change in diabetics compared to non-diabetics,
data on the usefulness of TyG index on subclinical ath-
erosclerosis according to diabetic status is currently un-
available. In clinical practice, brachial-ankle pulse wave
velocity (baPWV) is used as a simple and reliable tool
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for the measurement of arterial stiffness because of its
high reproducibility. Therefore, the present study evalu-
ated the association between TyG index and arterial




This is a cross-sectional investigation analyzing baseline
data collected for a prospective cohort study. We used the
data of 2560 subjects who participated in baseline health
examinations for a community-based cohort study in the
Seoul area between April 2010 and November 2012. Sub-
jects with a clinical history of cerebrovascular hemorrhage
or infarction, neurological abnormalities, or malignancy
were excluded from this study. The study protocol was ap-
proved by the local ethics committee of our institution,
and informed consent for the procedure was obtained
from each individual.
All blood samples were obtained after 8 h of fasting
and analyzed for triglycerides, high-density lipoprotein
(HDL) cholesterol, low-density lipoprotein (LDL) choles-
terol, and glucose. Waist circumference was measured at
the midpoint between the lower border of the rib cage
and the iliac crest. The TyG index was calculated as ln
[fasting triglycerides (mg/dL) × fasting glucose (mg/dL) /
2]. Body mass index (BMI) was calculated as weight (kg)
/ height (m2). Metabolic syndrome was defined as when
3 or more of the following were present: (a) blood pres-
sure ≥ 130 mmHg systolic or ≥ 85 mmHg diastolic or
anti-hypertensive treatment; (b) HDL cholesterol < 40
mg/dL in males or < 50mg/dL in females; (c) fasting tri-
glycerides ≥150mg/dL; (d) abdominal obesity based on
waist circumference ≥ 90 cm in males or ≥ 80 cm in fe-
males; and (e) impaired fasting glucose, defined as fast-
ing glucose ≥100 mg/dL or established diabetes based on
the American Heart Association/National Heart, Lung,
and Blood Institute (AHA/NHLBI) definition [8]. Dia-
betes was defined as either fasting glucose ≥126 mg/dL,
a referral diagnosis of diabetes, or antidiabetic treatment.
Measurement of baPWV
All subjects abstained from beverages or caffeine-con-
taining food for at least 45 min prior to baPWV meas-
urement. After a subject had been resting in the supine
position for at least 5 min in a quiet room, blood pres-
sure and baPWV were measured using an automated
waveform analyzer (Colin VP-2000, Colin Medical In-
struments Corp., Komaki, Japan). Briefly, baPWV was
measured in subjects’ bilateral upper and lower extrem-
ities using plethysmographic sensor that simultaneously
recorded blood pressure, an electrocardiogram, and
heart sounds. baPWV was calculated as the length be-
tween arterial sites divided by time interval and was
measured in both brachial and posterior tibial arteries.
The higher value of baPWV measured on either side of
each patient was used for analysis.
Statistical analysis
Continuous variables are expressed as the mean ± stand-
ard deviation. Categorical variables are presented as ab-
solute values and proportions. To compare the
characteristics among the TyG index groups, one-way
analysis of variance was used for continuous variables,
and the χ2-test or Fisher’s exact test was used for cat-
egorical variables, as appropriate. Correlational analysis
between the TyG index and baPWV was performed
using Pearson’s correlation test. Univariate and multi-
variate linear regression analysis was performed to iden-
tify the association between independent variables and
arterial stiffness. Variables with p < 0.05 in the univariate
analysis were considered confounding variables and en-
tered into multivariate linear regression analysis. All stat-
istical analyses were performed using the Statistical
Package for the Social Sciences version 19 (SPSS,
Chicago, Illinois), and a p-value of < 0.05 was considered
significant for all analyses.
Results
Baseline characteristics
Table 1 shows the clinical characteristics of the partici-
pants. All participants were stratified into four groups
based on their TyG index levels. The mean levels of
TyG index were 8.7 ± 0.2, 9.2 ± 0.1, 9.5 ± 0.1, and 10.0 ±
0.3 in groups I (lowest), II, III, and IV (highest), respect-
ively. There were significant differences in anthropomet-
ric indices, including BMI, waist circumference, and
systolic and diastolic blood pressure. The prevalence of
metabolic syndrome was 10.0, 19.1, 40.2, and 79.2% and
that of diabetes was 7.2, 9.1, 17.2, and 30.6% in groups I,
II, III, and IV, respectively.
Relationship between the TyG index and baPWV
The mean baPWV significantly increased with increasing
quartiles of the TyG index (group I [lowest]: 1421 ± 242
vs. group II: 1480 ± 244 vs. group III: 1534 ± 260 vs.
group IV [highest]: 1575 ± 279 cm/s; p < 0.001) (Fig. 1).
The levels of the TyG index were significantly correlated
with baPWV (r = 0.224, p < 0.001) (Fig. 2).
Association between clinical variables and baPWV
Univariate linear regression analysis showed that age (β
= 0.479, p < 0.001), male gender (β = 0.137, p < 0.001),
abdominal obesity (β = 0.083, p < 0.001), increased
blood pressure (β = 0.391, p < 0.001), decreased HDL
(β = 0.057, p = 0.004), smoking (β = 0.114, p < 0.001),
and TyG index (β = 0.224, p < 0.001) were significantly
associated with baPWV. Multivariate linear regression
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Table 1 Baseline characteristics
Quartile of the TyG index p
I (lowest) (n = 622) II (n = 658) III (n = 640) IV (highest) (n = 640)
Age, years 59 ± 8 60 ± 8 61 ± 8 60 ± 8 < 0.001
Male, n (%) 147 (23.6) 179 (27.2) 224 (35.0) 292 (45.6) < 0.001
Systolic blood pressure, mmHg 119 ± 14 122 ± 15 124 ± 15 127 ± 15 < 0.001
Diastolic blood pressure, mmHg 71 ± 10 73 ± 9 75 ± 9 77 ± 10 < 0.001
Heart rate, bpm 65 ± 9 66 ± 8 68 ± 10 69 ± 10 < 0.001
Anti-hypertensive drugs, n (%) 195 (31.4) 278 (42.2) 295 (46.1) 326 (50.9) < 0.001
Smoking, n (%) 114 (18.3) 134 (20.4) 188 (29.4) 259 (40.5) < 0.001
BMI, kg/m2 23.8 ± 2.9 24.5 ± 2.9 25.3 ± 2.9 25.8 ± 2.9 < 0.001
Waist circumference, cm 80 ± 8 83 ± 8 85 ± 8 87 ± 9 < 0.001
Laboratory
Total cholesterol, mg/dL 191 ± 33 198 ± 36 203 ± 37 205 ± 37 < 0.001
Triglyceride, mg/dL 66 ± 13 99 ± 13 133 ± 21 217 ± 81 < 0.001
HDL cholesterol, mg/dL 64 ± 15 57 ± 13 51 ± 13 45 ± 11 < 0.001
LDL cholesterol, mg/dL 114 ± 29 122 ± 32 128 ± 34 122 ± 35 < 0.001
Fasting glucose, mg/dL 93 ± 11 96 ± 11 101 ± 15 115 ± 31 < 0.001
Creatinine, mg/dL 0.76 ± 0.19 0.77 ± 0.18 0.79 ± 0.18 0.82 ± 0.20 < 0.001
Metabolic syndrome, n (%) 62 (10.0) 126 (19.1) 257 (40.2) 507 (79.2) < 0.001
Diabetes mellitus, n (%) 45 (7.2) 60 (9.1) 110 (17.2) 196 (30.6) < 0.001
Anti-diabetic treatment, n (%) 41 (6.6) 56 (8.5) 96 (15.0) 154 (24.1) < 0.001
TyG index 8.7 ± 0.2 9.2 ± 0.1 9.5 ± 0.1 10.0 ± 0.3 < 0.001
Values are given as the mean ± standard deviation or number (%)
BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, TyG triglyceride glucose
Fig. 1 Comparison of baPWV according to TyG index group
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analysis showed that age (β = 0.410, p < 0.001), male gender
(β = 0.051, p < 0.043), increased blood pressure (β = 0.266,
p < 0.001), and TyG index (β = 0.158, p < 0.001) were sig-
nificantly associated with baPWV (Table 2).
Relationship of TyG index to baPWV according to diabetic
status
Multiple linear regression models were analyzed to iden-
tify the association between TyG index and baPWV ac-
cording to the established diabetic status. TyG index was
independently related to the baPWV after consecutive
adjustment for confounding variables in both non-
diabetics and diabetics (Table 3).
Discussion
The main finding of present study was that the TyG
index was significantly associated with arterial stiffness
measured by baPWV after adjusting for other metabolic
abnormalities. This result provides evidence that IR has
a substantial role in subclinical atherosclerosis in a gen-
eral population.
The homeostatic model assessment of insulin resist-
ance (HOMA-IR) has been traditionally used to estimate
IR [9, 10]. However, insulin levels must be determined to
calculate the HOMA-IR index. In South Korea, insulin
levels are usually measured for established diabetics. Thus,
HOMA-IR is an inconvenient parameter to identify IR in
the general population. Recently, several studies reported
Fig. 2 Correlation between TyG index and baPWV
Table 2 Association between clinical variables and baPWV
Univariate Multivariate
β p β p
Age, years 0.479 < 0.001 0.410 < 0.001
Male 0.137 < 0.001 0.051 0.043
Abdominal obesity 0.083 < 0.001 −0.032 0.065
Increased blood pressure 0.391 < 0.001 0.266 < 0.001
Decreased HDL 0.057 0.004 −0.026 0.140
LDL > 130mg/dL 0.001 0.998
Smoking 0.114 < 0.001 −0.021 0.396
TyG index 0.224 < 0.001 0.158 < 0.001
HDL high-density lipoprotein, LDL low-density lipoprotein, TyG
triglyceride glucose
Increased blood pressure was defined as blood pressure ≥ 130 mmHg systolic
or ≥ 85 mmHg diastolic or anti-hypertensive treatment
Decreased HDL was defined as HDL cholesterol < 40 mg/dL in males or < 50
mg/dL in females
Table 3 Impact of TyG index on baPWV according to diabetic
status
Non-diabetes Diabetes
β p β p
Model 1 0.171 < 0.001 0.131 0.004
Model 2 0.161 < 0.001 0.126 0.006
Model 3 0.134 < 0.001 0.125 0.009
Model 4 0.137 < 0.001 0.122 0.011
HDL high-density lipoprotein, TyG triglyceride glucose
Definitions of increased blood pressure and decreased HDL are present in
Table 2
Model 1 Adjusted for age
Model 2 Adjusted for age and gender
Model 3 Adjusted for age, gender, abdominal obesity, increased blood
pressure, and decreased HDL
Model 4 Adjusted for age, gender, abdominal obesity, increased blood
pressure, decreased HDL, and smoking
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that the TyG index is closely correlated with HOMA-IR
[11, 12]. In addition, some studies suggested that the TyG
index had better predictive value for IR than HOMA-IR
[6, 13]. Thus, the TyG index is being considered as a sim-
ple and useful surrogate marker of IR.
Early detection of atherosclerosis is important for pre-
venting major CV events in the general population. In
clinical practice, subclinical atherosclerosis is mostly
evaluated at health check-ups with several tools, i.e.,
coronary artery calcium score (CACS), carotid
intima-media thickness, plaque, and pulse wave velocity.
Although IR might be a substantial risk factor for the
development of CV disease, few studies evaluated the as-
sociation between IR and subclinical atherosclerosis. In
particular, data on the relationship between the TyG
index and subclinical atherosclerosis have been limited.
Irace et al. reported that the TyG index is strongly
associated with carotid atherosclerosis, as assessed by
Doppler ultrasonography, after adjusting for traditional
CV risk factors [14].14 Importantly, they emphasized that
the TyG Index is better related to carotid atherosclerosis
than HOMA-IR. Kim et al. also reported similar findings
that the TyG index is more independently associated
with the presence of coronary artery atherosclerosis
assessed using CACS than is HOMA-IR in 4319 healthy
Korean subjects [15]. In the CRONOS-ADM (Coronary
CT angiography evaluation for clinical outcomes in
asymptomatic patients with type 2 diabetes mellitus)
registry, a higher TyG index is associated with increased
risk of coronary artery stenosis in asymptomatic subjects
with type 2 diabetes [16]. However, data on the associ-
ation between the TyG index and arterial stiffness has
been limited. The present study investigated the rela-
tionship between the TyG index and the arterial stiffness
assessed by baPWV in Korean adults without a previous
history of major CV events or malignancies. We also
found that the TyG index was significantly associated
with arterial stiffness after adjusting for confounding
factors.
It is well-known that IR is a major characteristic of
metabolic syndrome [8, 17]. Additionally, despite the dif-
ference in the clinical features of diabetes according to
ethnicity [18], IR has a pivotal role in the development
of diabetes. Recently, a longitudinal study performed in
2900 non-diabetic adults indicated that the TyG index
measured at a single point could be an indicator of the
risk for incident diabetes [19]. Participants with TyG
index ≥8.8 regardless of obesity had a significantly high
risk for diabetes in this study. We confirmed that the
prevalence of metabolic syndrome and diabetes signifi-
cantly increased with increasing quartiles of the TyG
index in the present study. Considering that IR has a
substantial role in metabolic abnormalities, IR might be
an important target to reduce the risk of CV disease.
Although previous studies reported the different athero-
sclerotic change in diabetics compared to non-diabetics,
we could identify that TyG index was useful IR param-
eter for predicting subclinical atherosclerosis in both
non-diabetics and diabetics.
This study has some limitations. First, the present
study includes only a Korean population. Second, we
have not been able to eliminate the possible effects of
underlying medications on subclinical atherosclerosis
because of the observational design of this study. Third,
the impact of IR on arterial stiffness may differ across
different age groups. However, it was difficult to perform
a sub-analysis of different age groups because none of
the cohort study participants were very young. Fourth,
we did not measure HOMA-IR because the examination
of insulin levels is not usually included in general health
check-ups at our institution. However, the close relation-
ship between the TyG index and HOMA-IR was already
well-established, as previous described. Fifth, we did not
have information on the physical activity of participants.
Finally, we did not evaluate the intra- and inter-observer
correlation coefficient for the measurement of baPWV.
However, it is well-known that the measurement of
baPWV is simple and reliable for identifying arterial
stiffness because of its high reproducibility [20, 21].
Despite these limitations, we could identify the inde-
pendent impact of the IR estimated by the TyG index on
arterial stiffness, which is an important marker of sub-
clinical atherosclerosis.
In conclusion, the TyG index was independently asso-
ciated with arterial stiffness measured by baPWV in a
relatively healthy Korean population. This result sug-
gested that that IR has a substantial role in subclinical
atherosclerosis and might be an important target to pre-
vent major CV disease.
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